サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1741385

細胞外マトリックス市場：コンポーネントの種類別、用途別、原料別、エンドユーザー別、製品種類別、技術別、治療領域別、機能別、生体材料の種類別、最終用途産業別、地域別

Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

出版日
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.71円
細胞外マトリックス市場：コンポーネントの種類別、用途別、原料別、エンドユーザー別、製品種類別、技術別、治療領域別、機能別、生体材料の種類別、最終用途産業別、地域別
出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞外マトリックス市場は、2025年には4,420万米ドルと推定され、2032年には7,480万米ドルに達すると予測され、2025年から2032年までのCAGRは7.8%で成長すると予測されます。

分析範囲 分析詳細
基準年 2024年 市場規模 (2025年) 4,420万米ドル
実績データ 2020～2024年 予測期間 2025～2032年
予測期間のCAGR (2025～2032年) 7.80% 予測金額 (2032年) 7,480万米ドル

細胞外マトリックス（ECM：細胞外基質）とは、組織や臓器内の細胞に構造的支持を与えるタンパク質と炭水化物の複雑なネットワークを指します。細胞接着、遊走、増殖、分化など、細胞の挙動を制御する上で重要な役割を果たしています。ECMはまた、成長因子やサイトカインの貯蔵庫としても機能し、様々な細胞プロセスに影響を与えます。

世界の細胞外マトリックス市場は、慢性疾患の有病率の増加、再生医療に対する需要の高まり、組織工学の進歩などにより、著しい成長を遂げています。市場を牽引しているのは、心血管疾患、整形外科疾患、皮膚潰瘍などの慢性疾患に罹患しやすい高齢化人口の増加です。さらに、外科手術の増加や効果的な創傷治癒ソリューションの必要性が、ECM製品に対する需要を促進しています。

しかし、市場はECMベースの治療法の高価格、厳しい規制要件、限定的な償還政策などの課題に直面しています。さらに、ECMベースの製品の利点に関する医療従事者や患者の認識不足が市場成長の妨げとなっています。

とはいえ、市場には革新的なECMベース製品の開発、学術機関と業界各社との提携、新興市場における製品ポートフォリオの拡大など、成長機会がいくつか存在します。さらに、個別化医療への注目の高まりや、ECM技術と他の先端治療との融合は、市場拡大の有望な展望をもたらします。

結論として、世界の細胞外マトリックス市場は、慢性疾患の有病率の増加と再生医療に対する需要の高まりに牽引され、今後数年間で大きく成長する見通しです。しかし、市場の潜在力を十分に発揮させるためには、高コストや限られた認知度といった課題に対処する必要があります。

市場力学：

世界の細胞外マトリックス市場は、慢性疾患の蔓延、組織工学の進歩、再生医療需要の高まりなど、いくつかの要因によって牽引されています。慢性疾患にかかりやすい高齢化人口の増加は、市場成長の主要な促進要因です。さらに、外科手術の増加や効果的な創傷治癒ソリューションの必要性が、細胞外マトリックス製品に対する需要を促進しています。

しかし、市場はECMベースの治療薬の高コスト、厳しい規制要件、限定的な償還政策などの課題に直面しています。ECMベースの療法はコストが高いため、より多くの患者層へのアクセスが制限され、市場成長の大きな障壁となっています。さらに、ECMベースの製品の承認には厳しい規制要件があり、一部の地域では償還政策が限られていることも市場拡大の妨げとなっています。

こうした課題にもかかわらず、市場には成長の機会がいくつかあります。生体活性スキャフォールドや組織工学コンストラクトなどの革新的なECMベース製品の開発は、市場拡大の大きな可能性を秘めています。学術機関と業界各社とのコラボレーションにより、技術革新がさらに促進され、高度なECM技術の開発が加速される可能性があります。さらに、再生医療の需要が高まっている新興市場での製品ポートフォリオの拡大は、市場成長の新たな道を開く可能性があります。

結論として、世界の細胞外マトリックス市場は、慢性疾患の蔓延や再生医療需要の高まりといった要因によって牽引されています。しかし、高コストや規制要件などの課題に対処する必要がある一方、新興地域における技術革新や市場拡大などの機会を活用する必要があります。

当レポートの主な特徴

  • 当レポートは、世界の細胞外マトリックス市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
  • また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
  • 「世界の細胞外マトリックス市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
  • 利害関係者は、世界の細胞外マトリックス市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向の分析

  • 市場力学
    • 促進要因
      • 慢性疾患の増加
    • 抑制要因
      • ECMベースの治療法の高コスト
    • 機会
      • 革新的なECMベース製品の開発
  • 影響分析
  • 主なハイライト
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • ポーターのファイブフォース分析
  • 企業合併・買収 (M&A) のシナリオ

第4章 世界の細胞外マトリックス市場：新型コロナウイルス感染症 (COVID-19) パンデミックの影響

  • COVID-19の疫学
  • 供給側と需要側の分析
  • 経済への影響

第5章 世界の細胞外マトリックス市場：コンポーネントの種類別（2020～2032年）

  • タンパク質
  • 糖タンパク質
  • プロテオグリカン
  • その他のECM分子

第6章 世界の細胞外マトリックス市場：用途別（2020～2032年）

  • 再生医療
  • 組織工学
  • 創傷治癒
  • ドラッグデリバリー
  • がん研究
  • その他

第7章 世界の細胞外マトリックス市場：原料別（2020～2032年）

  • 動物由来ECM
  • ヒト由来ECM
  • 合成ECM

第8章 世界の細胞外マトリックス市場：エンドユーザー別（2020～2032年）

  • 研究機関・学術センター
  • バイオテクノロジー・製薬会社
  • 病院・診療所

第9章 世界の細胞外マトリックス市場：製品種類別（2020～2032年）

  • ハイドロゲル
  • 足場
  • 脱細胞化ECM
  • ECMアナログ
  • その他

第10章 世界の細胞外マトリックス市場：技術別（2020～2032年）

  • 3Dバイオプリンティング
  • ナノテクノロジー
  • 細胞培養技術
  • 遺伝子工学
  • その他

第11章 世界の細胞外マトリックス市場：治療領域別（2020～2032年）

  • 整形外科
  • 皮膚科
  • 心臓病学
  • 神経学
  • 腫瘍学
  • その他

第12章 世界の細胞外マトリックス市場：機能別（2020～2032年）

  • 構造サポート
  • 携帯電話通信
  • 細胞接着
  • シグナル伝達

第13章 世界の細胞外マトリックス市場：生体材料の種類別（2020～2032年）

  • 天然ECM
  • 合成ECM

第14章 世界の細胞外マトリックス市場：最終用途産業別（2020～2032年）

  • 医療
  • 研究開発
  • 化粧品
  • 医薬品
  • その他

第15章 世界の細胞外マトリックス市場：地域別（2020～2032年）

  • 北米
      • 米国
      • カナダ
  • 欧州
      • 英国
      • ドイツ
      • イタリア
      • フランス
      • スペイン
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • ASEAN
      • オーストラリア
      • 韓国
      • その他アジア太平洋
  • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
      • その他ラテンアメリカ
  • 中東
      • GCC
      • イスラエル
      • その他中東
  • アフリカ
      • 北アフリカ
      • 中央アフリカ
      • 南アフリカ

第16章 競合情勢

  • Thermo Fisher Scientific
  • DSM
  • Acelity（KCI Concepts）
  • Corning Incorporated
  • Baxter
  • FUJIFILM Holdings Corporation
  • Integra LifeSciences
  • CellSystems Biotechnologie Vertrieb GmbH
  • Biotime, Inc.
  • Trevigen, Inc.
  • Advanced BioMatrix
  • Collagen Matrix, Inc.
  • Merck KGaA
  • VWR International LLC
  • REPROCELL USA Inc.
  • BioLamina AB
  • Matricel GmbH
  • Tissue Regenix
  • Admedus
  • MIMETAS

第17章 セクション

  • 分析手法
  • 出版社について
目次
Product Code: CMI6171

Extracellular Matrix Market is estimated to be valued at USD 44.2 Mn in 2025 and is expected to reach USD 74.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 44.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.80% 2032 Value Projection: USD 74.8 Mn

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes.

The global extracellular matrix market is witnessing significant growth due to the increasing prevalence of chronic diseases, rising demand for regenerative medicine, and advancements in tissue engineering. The market is driven by the growing aging population, which is more susceptible to chronic conditions such as cardiovascular diseases, orthopedic disorders, and skin ulcers. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for ECM products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. Moreover, the lack of awareness among healthcare professionals and patients about the benefits of ECM-based products hinders market growth.

Nevertheless, the market presents several opportunities for growth, including the development of innovative ECM-based products, collaborations between academic institutions and industry players, and the expansion of product portfolios in emerging markets. Furthermore, the increasing focus on personalized medicine and the integration of ECM technologies with other advanced therapies offer promising prospects for market expansion.

In conclusion, the global extracellular matrix market is poised for significant growth in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for regenerative medicine. However, challenges such as high costs and limited awareness need to be addressed to fully realize the market's potential.

Market Dynamics:

The global extracellular matrix market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in tissue engineering, and the rising demand for regenerative medicine. The growing aging population, which is more susceptible to chronic conditions, is a key driver for market growth. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for extracellular matrix products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Despite these challenges, the market presents several opportunities for growth. The development of innovative ECM-based products, such as bioactive scaffolds and tissue-engineered constructs, holds immense potential for market expansion. Collaborations between academic institutions and industry players can further drive innovation and accelerate the development of advanced ECM technologies. Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

  • This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
  • The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Detailed Segmentation:

  • Global Extracellular Matrix Market, By Component Type:
    • Proteins
    • Glycoproteins
    • Proteoglycans
    • Other ECM molecules
  • Global Extracellular Matrix Market, By Application:
    • Regenerative Medicine
    • Tissue Engineering
    • Wound Healing
    • Drug Delivery
    • Cancer Research
    • Others
  • Global Extracellular Matrix Market, By Source:
    • Animal-Derived ECM
    • Human-Derived ECM
    • Synthetic ECM
  • Global Extracellular Matrix Market, By End-User:
    • Research Institutes and Academic Centers
    • Biotechnology and Pharmaceutical Companies
    • Hospitals and Clinics
  • Global Extracellular Matrix Market, By Product Type:
    • Hydrogels
    • Scaffolds
    • Decellularized ECM
    • ECM Analogs
    • Others
  • Global Extracellular Matrix Market, By Technology:
    • 3D Bioprinting
    • Nanotechnology
    • Cell Culture Techniques
    • Genetic Engineering
    • Others
  • Global Extracellular Matrix Market, By Therapeutic Area:
    • Orthopedics
    • Dermatology
    • Cardiology
    • Neurology
    • Oncology
    • Others
  • Global Extracellular Matrix Market, By Function:
    • Structural Support
    • Cellular Communication
    • Cell Adhesion
    • Signal Transduction
  • Global Extracellular Matrix Market, By Biomaterial Type:
    • Natural ECM
    • Synthetic ECM
  • Global Extracellular Matrix Market, By End-Use Industry:
    • Healthcare
    • Research and Development
    • Cosmetics
    • Pharmaceuticals
    • Others
  • Global Extracellular Matrix Market, By By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • DSM
    • Acelity (KCI Concepts)
    • Corning Incorporated
    • Baxter
    • FUJIFILM Holdings Corporation
    • Integra LifeSciences
    • CellSystems Biotechnologie Vertrieb GmbH
    • Biotime, Inc.
    • Trevigen, Inc.
    • Advanced BioMatrix
    • Collagen Matrix, Inc.
    • Merck KGaA
    • VWR International LLC
    • REPROCELL USA Inc.
    • BioLamina AB
    • Matricel GmbH
    • Tissue Regenix
    • Admedus
    • MIMETAS

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Extracellular Matrix, By Component Type
    • Market Global Extracellular Matrix, By Application
    • Market Global Extracellular Matrix, By Source
    • Market Global Extracellular Matrix, By End-User
    • Market Global Extracellular Matrix, By Product Type
    • Market Global Extracellular Matrix, By Technology
    • Market Global Extracellular Matrix, By Therapeutic Area
    • Market Global Extracellular Matrix, By Function
    • Market Global Extracellular Matrix, By Biomaterial Type
    • Market Global Extracellular Matrix, By End-Use Industry
    • Market Global Extracellular Matrix, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • The increasing prevalence of chronic diseases
    • Restraints
  • High cost of ECM-based therapies
    • Opportunities
  • Development of innovative ECM-based products
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Extracellular Matrix Market, By Component Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Glycoproteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Proteoglycans
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other ECM molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Extracellular Matrix Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Extracellular Matrix Market, By Source, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Animal-Derived ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Human-Derived ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Synthetic ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Extracellular Matrix Market, By End-User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Research Institutes and Academic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Extracellular Matrix Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hydrogels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Decellularized ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • ECM Analogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

10. Global Extracellular Matrix Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 3D Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Nanotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cell Culture Techniques
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Genetic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

11. Global Extracellular Matrix Market, By Therapeutic Area, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

12. Global Extracellular Matrix Market, By Function, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Structural Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cellular Communication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cell Adhesion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Signal Transduction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

13. Global Extracellular Matrix Market, By Biomaterial Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Natural ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Synthetic ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

14. Global Extracellular Matrix Market, By End-Use Industry, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Healthcare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cosmetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

15. Global Extracellular Matrix Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

16. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Acelity (KCI Concepts)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Integra LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CellSystems Biotechnologie Vertrieb GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biotime, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trevigen, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced BioMatrix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Collagen Matrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • VWR International LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • REPROCELL USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioLamina AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Matricel GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tissue Regenix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Admedus
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • MIMETAS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

17. Section

  • Research Methodology
  • About us